Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma

Cancer Causes and Control

Volumn 25, Issue 7, 2014, Pages 809-817

  Hibler, Elizabeth A ^a,b   Sardo Molmenti, Christine L ^b,c   Lance, Peter ^a   Jurutka, Peter W ^d   Jacobs, Elizabeth T ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Mailman School of Public Health Columbia University ^*  (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Colon cancer; Colorectal adenoma; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; VITAMIN D; CALCITRIOL; CHOLAGOGUE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CAUCASIAN; CLINICAL EVALUATION; COLORECTAL ADENOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METACHRONOUS COLORECTAL ADENOMA; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; TUMOR LOCALIZATION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; ADENOMA; BLOOD; CLINICAL TRIAL; COLORECTAL NEOPLASMS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR; VERY ELDERLY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; CHOLAGOGUES AND CHOLERETICS; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; URSODEOXYCHOLIC ACID;

EID: 84904558231     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0382-6     Document Type: Article

References (60)

1. Haussler MR, Haussler CA, Bartik L et al (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66:S98-S112
2. Jafri NS, Gould M, El-Serag HB, Duan Z, Davila JA (2013) Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Dig Dis Sci 58: 2052-2060
3. Gawron AJ, Yadlapati R (2013) Disparities in endoscopy use for colorectal cancer screening in the United States. Dig Dis Sci 59(3):530-537
4. Laiyemo AO, Doubeni C, Sanderson AK 2nd et al (2011) Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc 74:253-261
5. Gandini S, Boniol M, Haukka J et al (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128:1414-1424
6. Lee JE, Li H, Chan AT et al (2011) Circulating levels of vitamin D and colon and rectal cancer: the Physicians'Health Study and ametaanalysis of prospective studies. Cancer Prev Res (Phila) 4:735-743
7. Touvier M, Chan DS, Lau R et al (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20:1003-1016
8. Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA, Martinez ME (2007) Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol 103:752-756 (Pubitemid 46401330)
9. Slattery ML, Neuhausen SL, Hoffman M et al (2004) Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer 111:750-756 (Pubitemid 39062899)
10. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E (2008) Vitamin D and prevention of colorectal adenoma: a metaanalysis. Cancer Epidemiol Biomarkers Prev 17:2958-2969
11. Zheng XE, Lipka S, Li T et al (2013) The relationship of vitamin D status, smoking, and colorectal adenoma: a retrospective study in an ethnically diverse community. J Steroid Biochem Mol Biol 136:280-283
12. Bouillon R, Lieben L, Mathieu C, Verstuyf A, Carmeliet G (2013) Vitamin D action: lessons from VDR and Cyp27b1 null mice. Pediatr Endocrinol Rev 10(Suppl 2):354-366
13. Ryan JW, Anderson PH, Turner AG, Morris HA (2013) Vitamin D activities and metabolic bone disease. Clin Chim Acta 425C: 148-152
14. Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17:2302-2305
15. Jacobs E, Martinez ME, Buckmeier J, Lance P, May M, Jurutka P (2011) Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. J Carcinog 10:3
16. Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502-1508 (Pubitemid 39202318)
17. Platz EA, Hankinson SE, Hollis BW et al (2000) Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 9:1059-1065
18. Alberts DS, Martinez ME, Hess LM et al (2005) Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97:846-853 (Pubitemid 40909127)
19. Ritenbaugh C, Aickin M, Taren D et al (1997) Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial. Cancer Epidemiol Biomarkers Prev 6:347-354 (Pubitemid 27204026)
20. Egan JB, Thompson PA, Ashbeck EL et al (2010) Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res 70:1496-1504
21. Hollis BW (2007) Assessment of circulating 25(OH)D and 1,25(OH)2D: emergence as clinically important diagnostic tools. Nutr Rev 65:S87-S90
22. Jacobs ET, Alberts DS, Foote JA et al (2008) Vitamin D insufficiency in southern Arizona. Am J Clin Nutr 87:608-613 (Pubitemid 351364541)
23. Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129: 125-137 (Pubitemid 19030705)
24. Hong SN, Kim JH, Choe WH et al (2012) Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: a case-control study. Dig Dis Sci 57:753-763
25. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29:3775-3782
26. Jacobs ET, Hibler EA, Lance P, Sardo CL, Jurutka PW (2013) Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer 133:2980-2988
27. Thompson PA, Wertheim BC, Roe DJ et al (2009) Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prev Res (Phila) 2:1023-1030
28. Thompson PA, Wertheim BC, Roe DJ et al (2009) Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prev Res (Phila Pa) 2:1023-1030
29. Moan J, Lagunova Z, Lindberg FA, Porojnicu AC (2009) Seasonal variation of 1,25-dihydroxyvitamin D and its association with body mass index and age. J Steroid Biochem Mol Biol 113:217-221
30. Dixon KM, Mason RS (2009) Vitamin D. Int J Biochem Cell Biol 41:982-985
31. Liu S, Gupta A, Quarles LD (2007) Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329-335 (Pubitemid 46944331)
32. Marsell R, Jonsson KB (2010) The phosphate regulating hormone fibroblast growth factor-23. Acta Physiol (Oxf) 200:97-106
33. Marsell R, Mirza MA, Mallmin H et al (2009) Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men. Osteoporos Int 20:1167-1173
34. Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101:403-408
35. Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 10:219-229
36. Jacobs ET, Thompson PA, Martinez ME (2007) Diet, gender, and colorectal neoplasia. J Clin Gastroenterol 41:731-746 (Pubitemid 47267759)
37. Bufill JA (1990) Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779-788
38. Albuquerque C, Baltazar C, Filipe B et al (2010) Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosom Cancer 49:746-759
39. Gervaz P, Bucher P, Morel P (2004) Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 88:261-266 (Pubitemid 39601269)
40. Koestler DC, Li J, Baron JA et al (2013) Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon. Mod Pathol 27(1):145-155
41. Slatter ML, Yakumo K, Hoffman M, Neuhausen S (2001) Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control 12:359-364 (Pubitemid 32553629)
42. Slattery ML, Wolff RK, Curtin K et al (2009) Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res 660:12-21
43. de Jonge V, Sint Nicolaas J, van Leerdam ME, Kuipers EJ, Veldhuyzen van Zanten SJ (2011) Systematic literature review and pooled analyses of risk factors for finding adenomas at surveillance colonoscopy. Endoscopy 43:560-572
44. Gao QY, Chen HM, Sheng JQ et al (2010) The first year follow-up after colorectal adenoma polypectomy is important: a multiple-center study in symptomatic hospital-based individuals in China. Front Med China 4:436-442
45. Caldarella A, Crocetti E, Messerini L, Paci E (2013) Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study. Int J Colorectal Dis 28:637-641
46. Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB (2011) Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer 128:1668-1675
47. Ding EL, Mehta S, Fawzi WW, Giovannucci EL (2008) Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int J Cancer 122:1690-1694 (Pubitemid 351413414)
48. Protiva P, Cross HS, Hopkins ME et al (2009) Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res (Phila) 2:43-51
49. Papaxoinis K, Triantafyllou K, Sasco AJ, Nicolopoulou-Stamati P, Ladas SD (2010) Subsite-specific differences of estrogen receptor beta expression in the normal colonic epithelium: implications for carcinogenesis and colorectal cancer epidemiology. Eur J Gastroenterol Hepatol 22:614-619
50. Egan JB, Thompson PA, Vitanov MV et al (2010) Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol Carcinog 49:337-352
51. Palmer HG, Gonzalez-Sancho JM, Espada J et al (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154:369-387 (Pubitemid 34286147)
52. Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491S-499S
53. Jacobs ET, Van Pelt C, Forster RE et al (2013) CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73:2563-2573
54. Abbas S, Linseisen J, Slanger T et al (2008) The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 17:1339-1343
55. Lauridsen AL, Vestergaard P, Hermann AP et al (2005) Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxyvitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77:15-22 (Pubitemid 41504168)
56. Hibler EA, Jacobs ET, Dampf Stone A, Sardo CL, Galligan MA, Jurutka PW(2014) Associations between vitamin D binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer Prev Res (Phila) 7(4):426-434
57. Hibler EA, Hu C, Jurutka PW, Martinez ME, Jacobs ET (2012) Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 21:368-375
58. Jacobs ET, Scragg R (2008) Vitamin D and health. Complet Nutr 3:7-9
59. Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J (2009) The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 29:3713-3720
60. Carter GD, Phinney KW (2014) Assessing vitamin D status: time for a rethink? Clin Chem. doi:10.1373/clinchem.2013.219386